Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01342315 · ClinicalTrials.gov registry record · Phase 3
Topical Antifungal Treatment for Tinea Cruris
A Phase 3 study, sponsored by Medicis Global Service Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 483
- Enrollment target
NCT01342315: Completed Phase 3 study, sponsored by Medicis Global Service Corporation.
NCT01342315 is a Phase 3 study that has completed, run by Medicis Global Service Corporation. The registered enrollment target is 483 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (37% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01342315, a Phase 3 study, has completed, sponsored by Medicis Global Service Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 483 participants
- Enrollment target
Study Summary
To determine if a topical antifungal cream is safe and effective for the treatment of tinea cruris
Primary Outcome
Signs and Symptoms Severity Score and negative Potassium Hydroxide (KOH) and Culture
Interventions
- DRUG Placebo
- DRUG 33525
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 483 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-05 |
| Phase | Phase 3 |
What the finished NCT01342315 record still lists
NCT01342315 is an interventional study that assigns participants to a tested intervention. The registered 483 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (37% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01342315 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01342315 about?
NCT01342315 is a clinical study titled "Topical Antifungal Treatment for Tinea Cruris". To determine if a topical antifungal cream is safe and effective for the treatment of tinea cruris
What is the current status of trial NCT01342315?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 483 participants. The study started on 2011-05. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01342315?
The interventions under investigation include: Placebo (DRUG), 33525 (DRUG).
Who is sponsoring clinical trial NCT01342315?
This trial is sponsored by Medicis Global Service Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01342315's enrollment target sits among peer trials
483 792nd of 2000 higher than 1,209 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02871726 · 483 participants · NA
Transrectal Ultrasound Robot-Assisted Prostate Biopsy
- NCT05421741 · 484 participants · Phase 4
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
- NCT04449458 · 482 participants · NA
The Positively Quit Trial for Smoking Cessation
- NCT07079631 · 482 participants · Phase 1
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia